Articles published by Prolific Machines

Prolific Machines Selected to Join FDA's Emerging Technology Program, Advancing the Company’s Novel Biomanufacturing Platform

May 21, 2025

From Prolific Machines

Via Business Wire

Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors

May 15, 2025

From Prolific Machines

Via Business Wire

Prolific Machines Announces the Completion of Optogenetic Bioproduction at 200L, Marking the World’s Largest Demonstration of Optogenetics to Date

April 17, 2025

From Prolific Machines

Via Business Wire

Prolific Machines Announces the Appointment of Former Forge Biologics Executive, Christina Perry, as CFO Setting the Stage for Optogenetics Leader’s Biopharmaceutical Commercial Ramp Up

February 13, 2025

From Prolific Machines

Via Business Wire

Prolific Machines Receives Grant to Develop a Platform to Produce Affordable Monoclonal Antibodies to Prevent Infectious Disease in Low- and Middle-Income Countries

August 14, 2024

From Prolific Machines

Via Business Wire

Prolific Machines to Harness Light to Deliver Unprecedented Cellular Control, Enabling Higher Quality and Never-Before-Possible Biosolutions — Beginning a New Era of Biotechnology

June 06, 2024

From Prolific Machines

Via Business Wire

Prolific Machines Raises $42M From Top Planetary Health Investors to Build the Assembly Line for Biology

September 14, 2022

From Prolific Machines

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Articles published by Prolific Machines

Starting at $3.75/week.

Subscribe Today